vimarsana.com
  1. Home
  2. Live Updates
  3. Company Activity Under Research Agreements - Breaking News

Latest Breaking News On - Company activity under research agreements - Page 1 : vimarsana.com

Innocan Pharma Corporation: Innocan Pharma Provides Annual State of the Business Update

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - February 16, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology

Israel generalUnited statesTel avivMerav shamirDennis riedlIris bincovichNissim vasilevskiKenji kitataniEva reuterEyal kaloCompany or innocanAdditional researchDrug administrationInnocan pharma corporationBi sky global ltdKoret school of veterinary medicine hospital

InnoCan Pharma : MD&A report - 31 12 2021

INNOCAN PHARMA CORPORATION Management s Discussion and Analysis For the year ended December 31, 2021 1. MANAGEMENT S DISCUSSION AND. | April 24, 2022

Israel generalUnited statesChezy barenholzInternational financial reporting standardsInnocan pharma corporation the companyInnocan pharma corporationInnocan pharma ltdHebrew university of jerusalemCompany activity under research agreementsCanadian securities exchangeDescription of the company principal businessesTechnology transfer company of tel aviv universityTel aviv universityAnalysis forPharma corporationCanada business corporations acton may

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.